the Imperial College Innovation Fund
The Imperial College Innovation Fund is an investment vehicle affiliated with Imperial College London, a top-two global university that commercializes research across STEM and business through spinouts and partnerships, most recently demonstrated by the Myricx Bio-Novartis acquisition agreement.
- Company typePrivate
- Founded1907
- HeadquartersLondon, United Kingdom
- Headcount—
- GTM typeB2B
- OfferingServices
What the Imperial College Innovation Fund does
The Imperial College Innovation Fund is referenced as an investment firm affiliated with Imperial College London. The source material almost exclusively describes the parent university rather than the fund vehicle itself, so the fund's mandate, AUM, portfolio, and investment criteria cannot be characterized with specificity from the inputs.
Imperial College London is an independent higher education corporation established by Royal Charter in 1907, operating as an exempt charity under the Charities Act 2011. It is a global top-ten university headquartered at its South Kensington Campus in London, with additional campuses at White City, Hammersmith, St Mary's, Charing Cross, Royal Brompton, Chelsea & Westminster, Northwick Park, and Silwood Park. The institution is ranked No.2 in the world and No.1 in Europe and the UK in the QS World University Rankings 2027 (held for three consecutive years), was named University of the Year for Graduate Employment by The Times and Sunday Times Good University Guide 2026, and received a Gold Award in the Teaching Excellence Framework 2023. Imperial's affiliates include 14 Nobel Prize winners and 3 Fields Medal winners.
Imperial delivers education and research across science, technology, engineering, medicine, and business through faculties of Engineering, Medicine, Natural Sciences, and Imperial Business School. It operates formal commercial and translational arms — Imperial Consultants, Shop Imperial, Imperial College Healthcare NHS Trust, and Imperial College Health Partners — and runs active spinout activity, exemplified by the Myricx Bio acquisition agreement with Novartis. Recent strategic initiatives include the School of Convergence Science (mission areas covering Health and Technology, Sustainability, Space/Security/Telecoms, and Human and Artificial Intelligence), WestTech London, Imperial Global, and the Sustainable Imperial Strategy 2026-2031. As a fund vehicle, the Innovation Fund appears positioned to capture and commercialize this institutional research pipeline.
the Imperial College Innovation Fund firmographics
Firmographics- Name
- the Imperial College Innovation Fund
- Legal name
- Imperial College London
- Website
- https://imperial.ac.uk
- Company type
- Private
- Founded year
- 1907
- Operating status
- Operating
- Short description
- The Imperial College Innovation Fund is an investment vehicle affiliated with Imperial College London, a top-two global university that commercializes research across STEM and business through spinouts and partnerships, most recently demonstrated by the Myricx Bio-Novartis acquisition agreement.
- Ownership category
- akta.pro rank
the Imperial College Innovation Fund industry classification
Industry- Product category
- Venture Capital
- NAICS
- Other Investment Pools and Funds (5259), All Other Financial Investment Activities (52399), Miscellaneous Financial Investment Activities (523999)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)
- akta.pro secondary industry
- International & Global Research Universities (Multi-Campus/International Footprint) (EDAHABAI)
Keywords
Where the Imperial College Innovation Fund is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
the Imperial College Innovation Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Others
the Imperial College Innovation Fund product offering
Product offeringCore offering
The Imperial College Innovation Fund is described as an investment firm. It operates in association with Imperial College London, a top-ranked global university, and provides investment-related services tied to the university's research and innovation ecosystem. Specific fund structure, size, and portfolio details are not disclosed in the provided source material.
Differentiator
Problem solved
Functional benefit
Brands
- Imperial Business School: The business school arm of Imperial College London offering MBA and executive education programs.
- Imperial College Healthcare NHS Trust
- Imperial College Health Partners
- Imperial Consultants
- Shop Imperial
Products and services
- Imperial College Innovation Fund (Investment Vehicle)
Companies that use the Imperial College Innovation Fund
Customer profileSegments1 record
Ideal customer profiles1 record
the Imperial College Innovation Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
the Imperial College Innovation Fund partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
the Imperial College Innovation Fund competitors and assessment
Company assessmentBroad incumbents
- MIT Investment Management Company: MIT's investment office managing the university's endowment and related investment activities. Comparable as a top-tier US research university investment organization with established commercialization capabilities, though broader in scope.
- StartX: Stanford-affiliated startup accelerator supporting founders from the Stanford ecosystem. Comparable as a top research university-affiliated innovation platform, though broader in scope than pure investment activity.
Direct peers
- Cambridge Innovation Capital: UK university-affiliated venture fund investing in deeptech and life sciences spinouts from Cambridge and the wider Cambridge ecosystem. Closely comparable as a leading UK research-university investment vehicle with similar thesis and structure.
- Oxford Science Enterprises: Investment company created by Oxford University to commercialize its research. Highly comparable in mission, structure, and scale as a UK research-university spinout investor with a STEM focus.
- Apollo Therapeutics: Biomedical-focused investment firm backed by UK universities including Imperial, UCL, and Cambridge. Direct peer for Imperial-affiliated biomedical investment activity with overlapping university LPs.
- IP Group: UK-listed intellectual property commercialization company partnering with research-intensive universities including Oxford, Cambridge, and Imperial. Directly comparable in university IP commercialization focus and listed-market scale.
- UCL Technology Fund: Early-stage technology investment fund associated with UCL focused on commercialization of UCL research. Direct UK university fund peer with overlapping themes in STEM, life sciences, and deeptech spinouts.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
the Imperial College Innovation Fund social profiles
Digital presencethe Imperial College Innovation Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
the Imperial College Innovation Fund leadership team
Management profileNumber of profiles
the Imperial College Innovation Fund subsidiaries and ownership
Company hierarchySubsidiaries1 record
the Imperial College Innovation Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
the Imperial College Innovation Fund M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about the Imperial College Innovation Fund
What does the Imperial College Innovation Fund do?
The Imperial College Innovation Fund is described as an investment firm. It operates in association with Imperial College London, a top-ranked global university, and provides investment-related services tied to the university's research and innovation ecosystem. Specific fund structure, size, and portfolio details are not disclosed in the provided source material.
Is the Imperial College Innovation Fund a public or private company?
the Imperial College Innovation Fund is a private company. It is classified as unknown and is currently operating.
When was the Imperial College Innovation Fund founded?
the Imperial College Innovation Fund was founded in 1907.
Where is the Imperial College Innovation Fund based?
the Imperial College Innovation Fund is headquartered in London, United Kingdom, in the Europe region.
Who are the Imperial College Innovation Fund's main competitors?
Broad incumbents on record are MIT Investment Management Company and StartX. Direct peers are Cambridge Innovation Capital, Oxford Science Enterprises, Apollo Therapeutics, IP Group and UCL Technology Fund.
Does the Imperial College Innovation Fund have an API?
No public API is recorded for the Imperial College Innovation Fund.
What industry is the Imperial College Innovation Fund in?
the Imperial College Innovation Fund's product category is Venture Capital. Its primary akta.pro industry code is EDAHABAH, Technology Transfer & Innovation-Driven Research Universities (High Commercialization), with a secondary code of EDAHABAI, International & Global Research Universities (Multi-Campus/International Footprint). Its NAICS code is 5259 and its SIC code is 6282.